overall survixal (,')-ll). Despite the-failure of these large-raiidomize-cl trials lo eure-llu-nia|oril\ ol palic-nts, llu-pote-utial for cure in some jialicnls with c-arly Ml'' provides greal impc-lus for cslablislung this diagnosis as early in ils elcve-lopnu-iU as possible-. I Ie)we-\-ei, a palie-iil c-ousiderecl lo lia\-c-MI' c:liiiically may ree|iiire-many years and liumcreius biopsic-s be-lc)re-llu-cliannoslic-histology is ree-e)gnizc-d at llu-light niie-ic)se-e)|)ic-Icve-l (12). Flu-principle obstacle is the light microscopic asscssme-nt of early C'FC.L in the-diirc-rc-ntialion hy the pathe)logist ot llu-lyniplie)pre)hlcrati\-e F cells of MF from benign, reactixe F cells associate'd with iullaiiimateiry skill disease-. In an c-HoiI lo ovc-rconu-llicsc liniilalie)ns in ree-ognizing early MF, several diHerent technique-s, iiuliiding T cell rece»pte)r ('FCK) gene rearraiigc-nu-nt studies and immunophenolypiiig of F cell markers, have been proposed as useful tools available lo helj) the diagnosis of MF (IS. 14), MoIc-culai-basc-d lc-clinic|iics ha\c-altc-mptcd to disce-rn a elcinal popuialion of'F cells that was not a])parent on |-e-\icvv ol routine lu-nialoxylin/eosin-slainc-d sections.
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Immunodiagnosis in cutaneous T cell lymphoma: how does gene expression of the variable region of the T cell receptor fit into the diagnostic and pathophysiological picture of T cell neoplasia In acKance-d MF case-s, sin\i\-al has t;c-iie-iall\" been |)oor (2, 3) , Howe-vc-r, some-rc-ports ha\T-siiggesled a curative potential (dc-fiiic-d as bc-iiig discasefn-e eight years aftc-r trealnie-nl is disc-onlimic-d) in e-arly (Stage-1) MF wilh lo|)ic-al nilroge-n miislarel aiul/eir leila! skin e-leclrein-be-ain ihe-rapy (2-8),
Olhe-rs lia\e-re-porle-d eeimbine-d luodalily appreiaclu-s with c-nc-ouragiug rcsiills iu ihc-e-aiK sla.^e-s e)l M F, bul no sii;nilic-aul impren c-mc-iils lii overall survixal (,')-ll). Despite the-failure of these large-raiidomize-cl trials lo eure-llu-nia|oril\ ol palic-nts, llu-pote-utial for cure in some jialicnls with c-arly Ml'' provides greal impc-lus for cslablislung this diagnosis as early in ils elcve-lopnu-iU as possible-. I Ie)we-\-ei, a palie-iil c-ousiderecl lo lia\-c-MI' c:liiiically may ree|iiire-many years and liumcreius biopsic-s be-lc)re-llu-cliannoslic-histology is ree-e)gnizc-d at llu-light niie-ic)se-e)|)ic-Icve-l (12). Flu-principle obstacle is the light microscopic asscssme-nt of early C'FC.L in the-diirc-rc-ntialion hy the pathe)logist ot llu-lyniplie)pre)hlcrati\-e F cells of MF from benign, reactixe F cells associate'd with iullaiiimateiry skill disease-. In an c-HoiI lo ovc-rconu-llicsc liniilalie)ns in ree-ognizing early MF, several diHerent technique-s, iiuliiding T cell rece»pte)r ('FCK) gene rearraiigc-nu-nt studies and immunophenolypiiig of F cell markers, have been proposed as useful tools available lo helj) the diagnosis of MF (IS. 14), MoIc-culai-basc-d lc-clinic|iics ha\c-altc-mptcd to disce-rn a elcinal popuialion of'F cells that was not a])parent on |-e-\icvv ol routine lu-nialoxylin/eosin-slainc-d sections.
In addition to diagnostic preiblenis relatc-d to C I'(;F, the-ctie)logy of C'FCF has remaiiu-d largely unknown. One theeiry ni\x)l\-es ehreinic en\ iroiime-iital auUi;e-nic siiniulalion (K'l). Recent rc-poris ol increased numbe-rs ol <intige-n-prc-seiilnig cc-lls in Ml" would lend lo support llic-noliou thai chronic antigenic-siiniulalion is a factor in the dc-Nclopme-iil of MF (Hi). A casc--cc)iilrolled sludy, however, showed no associatc-d ciu-ironniciital laclors in 100 palu-nls (17). Only lliose cases of C'FCF associalc-d with the ITFFV'-I rc-lro\-iriis lia\-e been c-onc-liisi\-e-l\ rclale-d lo ;v specific, Irausniissibk-, cxoge-ncnis age-\U (,1H), VVhai is kneiwn about MF/C'FCL is lhal il is a clonal prolifcralieMi e)f F cells which are usually CD3-f-. CD4-I-(helper), CD29+, CD45RO-I-, CD4.'iRA nu-morv 'F cells (12) (13) (14) . Mosl e\isc-s of advanced disc-ase have-a (lonal gene rearrangement in the TCR as detected by Southern blot analysis (12, 19) . lvirly lesieins, henvever, are-usually eibse-rve-el tej ee)ntain the-I CR in its ge-rmliiu-configuratieiu, suggesting that there-may be-[no few mcjiioclonal neoplastic cells for deteetion by conventional Southe-rn blot analysis (13, 20) . I'.veu more eslablishe'd |)lae|iie-stage Ml'" le-sie)ns may have TCR ge'rmline ce)nfiguratioiis (21) .
The human IXIR re-ce-|)tor is a lu-tere)diinc-r of al|)ha and beta eliains which are iic)ii-co\ alenlly associated with tlie Cl)3 molecule on the-I" cell surface' (22) . The aljilia and beta chains are striictiirally similar to iimiiiinoglobulins (23, 24) . The' D.NA sec|uences and genes whieh ence)de these chains are a (-oinplex cluster of variable (V), constant (C), dive'rsity (D), and jeiiuing (J) segme-iits, all sepaiate-cl by nejii-transeribed e'xe)ns. During the normal jjrejeess of gene rearrangement afler anligenic exposure, the beta chain has each segment adjoined by the actie)n of the recombinase enzyme system so that a unic|ue, functie)nal V-D-J-C gene is a.ssemblee:! (22) (23) (24) . A similar |3rocess occurs for the alj^ha cliain except no D segments are involved (22) . Ihe prejce'ss of rearrangement is thought te) occur in the-thyniiis. The' V rcgie)n e)f the beta chain (V(3) ic-prc-sents a cluster of .some 60 funetional genes whic:h have been groujied into 20 familic-s based on > 75% secjuenc-e homology (24) . 'Fhis limilation of diversity is eom|)ensated for by varying combinations of J and I) genes along with the random insertion of ne)n-germline nucleotides (25) .
This limited number of VP gene families has alleiwe'd develejpment of family speciiic MoAbs. These antibodies are an exciting advanc-ement in immime)-Ijatheilogy as they provide a way to dissect the biologic nature e)f I' cell infiltrates. These MoAbs ha\e' the-potential te) recognize monoclonal vs olige)-e le)nal vs polyclonal dermatoses and assist in correlatieins between etiole)gy and inorphc)le)gy (2(), 27).
In this issue, Cilks et al. (28) report that eight of eight jKUients wilh C TCL lacked any reslrictecl (i.e. clonal) V("5 gene usage. This contradicts the report by Jack e-t al whe're-lO/lfi patients showed a predominanec of VP,| expressing V cells (29). The restricted V(3 gene usage amongst dilferent cases of CrCL is of polenlial e'liopathe)logical as well as diague)slic signilicanee-, be-catise it may inclicalc-that some common antige'ii is inve)lved in these T c-ell neoplasias (29). Rec-ognilion of inliltrate-s whieh pre-(lominalely ex|)re.s.s a single V^ gene' product allows rec-e)guitie)n in .situ eil clonal proliferations. 1 his lechniquc could also eliminate the costly routine use of Southern analysis e)( DNA in search for clonality in T cell neoplasia. VPr, was expres.sed by 99% of circ:ulaliug c:ells in one jialienl with Sezary syndrome and also by ihe majority of cutaneous infiltrating 'f cells in this |)atie'nt (!5t)). Nine-of 10 Ml'' patients showeel ne) predomiiianee-or\'("5 gene' |)ie)duet expression, or even aggregations ol posUive cell;-that might suggest |)rolileration of elone-(s) leiealh using a panel eif seven V^ Me)Abs (3t)). Clark e't al re])e)rted similar low rates ofV(3 expression in a 198( report whei'e 2/24 V eell lymphomas were \'(^ii4 and 1/24 was V(i,-F(31). Charley et al and ()X;rach el al screened a total of 38 V cell iie-o|ilasins aiie found 6/3H with re'stric:ted VP expression (2(), 27) Rallkier et al (32) studied 45 CTfCL patic-nts aiK found \'\\ in 2/45, V(3., in 1/45, \'\\ in 1/45, aiie V[3|2 in 1/45 patients, but no |iredeiminant V|) lain ily ex|)ressie)u in the' either 40 |iatie-nts.
To siimmaiize these reports, a total ol 142 C I Cl. patie'iits were screened with from 2-7 Vp specific MoAbs aiiel 25/142 (18"/,) case-s sheiwe-d icstric-tccl VP expressiem. Of ihese, 18 were' \'P», 4-VPr,, 2-\'\\. and 1-VPi^. Thus, it eurrently ap]3ears that considerable variability in VP expression exists in CTCL, but ihat a sub-popiilatie)n of C'FC.L eases ean be associated with VPn exiiression. These lindings in CICL are somewhat similar to a ic'|)oi-t ol iionHodgkin's T eell lym|)he)ma in whieh in 29"/<i ol TCR positive lymphomas, the neo]5lastie cells cU'iiionstrated a restricted VP tisage ti.sing a |)anc-l of 7 dilferent reagents (33) . It shotild be-noted that just identifying a cell |io]5ulation with restrieted VP gene expre'ssie)n deie-s ne)t necessarily |)ro\-e eithe-r a meiiieiclonal e)r inalignant jirocess. Ce'rtain antigens (i.e. staphylococcal superantigens (34) may ])rove)ke' an ejligcjclonal response', and increased i)opiilalie)ns ol VP 8-1-cells have already been obse-rveel in saieeiiclosis and Crohn's disease (35, 36).
'Ihere is also consideral)le |5revie)us weiik in Cl C'L using the' presence or absenee ol various cell surfaee antigens (e.g. Leu-8 and Leu-9) lor diagnostic pur|)c)sc-s. Lc'u-8 (the peripheral lymph nodehoming re'ee])tor) and Le'U-9 (CD-7) are' iie)rnially expressed by the-majority ol resting I eells, but are down-regulated during activation along with HLA-DR up regulalion (37) . Reports suggesting absence of these markeis as suHicient criteria for the diagnosis of CTCL have been found in only a minority of cases (38). Moreover, the recognition tbat Leu 8 may be le)st diiring le)c-al f ec-ll aelivalioii in the skin has stiggesletl the tieed to te-exatnine' the diagnoslic sensitivity eil tlie-se marke-rs in distinguishing benign from malignant T cell infiltrates (37) . This discrepaney has been partially resolv-ecl llirough tlie use of stricter criteria te) define whai is meant by delicieney. l'ieker et al report that cinly CTCL will be recognized if > .5O'X, leiss of (;i)7/ Leu-9 or Le'u-8 is used as a eulolf (14) . Similar stringenl criteria need to be devele)ped be'lore VP antigc-ii c-xpression ean be routinely inc-orporau'd into the analysis ol potenlial CTCL s|K'cimeiis. We nope that a wide variety of hoi h acute and chronic T ,(•11 rc-active cutaiuMius eruptions such as allergic :(nta(t dermatitis, i^soriasis, aloi)ic clermatilis, and piityriasis lie henoicles cases will he ftilly explored (br ' P usage to complement the ]nil)lication of C'FCL • a'scs, so as to a\oicl some o( the iniinimogical jjit-:;ns in clistiiigiiisliing C'TCL (roiu benign processes.
Why should there be so much variability amongst iilr.sc diderent reports on the exi^ressioii of V' (3 gene piodiicts in C'I'C'F:' Several possible ex|)lanations ,i|jst 1)'' considered in attem|)ting to answer ihis , Jc'Stion. '1 he first is pm'ely technical and it may , rll be thai dideicnt laboratories use diderent tech-;;,jques and dideicnt MoAhs, as discussed 1)\ Gilks , j.al in this issue (28). Also, the potential uiimasking , I'c-cTlain V'P,, epitopes during fixation procedures niay make the MNll antibody more reaetive with i niphoc-ytes in tissue section (29). 'Fissue cross reictivity and restriction of epitopes may also be di(-!,-rent between the various V(3,, clones used in these sttidies. As many as five VP,, sub-families have been described (25) , thus it is quite conceivable that di(-K rent MoAbs may well recognize clidering epitojjes I ,•tween these stib-faniilies. Another recent study by . lark and Boylston, however, demonstrated that IX 1 1 MoAh was randomly expressed in reactive ivmph node in a cell surface/imtteni (39) . Thus, it is • inlikely thai the 10/16 MXl 1-f MF cases reported by jack c^t al (29) were solely the results of nonspecific staining.
Other possible c^xplanalions (or the disparate expression of certain V(3 gene families in Cl'CL iiiv(il\CS \ ariations in liimor biology. Ii is possible that (lie diderent groups have sttidied patients from dilieiciit environmental ciiciimstances Fhe patients of lack el al WCTC |)icsumal)ly i)iccloniinantly Scottish, whereas Rallkiaer et al studied mainly l^anish ])a-(ieiits, (iilks el al mainly Canadian i)alients, (Mark rX al |)riinaiily Biilish ancl Hunt et al were primarily from Piltshiugh (26-30). l( an exogenous (actoi(s) is/are invoked in the pathogenesis ofC^'FCL, dilierciU antigenic stimulants in these dilferent regions could lead to clillerent nialignanl clones expressing anligc'ii-specilic \'(3 gene products. 'Fhtis, it is coucei\ablc that the groiij) of V' lS,,-!-|)atients iei)orts by Jack (all Scollish) along with tlie scattered other V(^(j+ cases all rc'|)resent a common antigenic stimulant and/or common ancestry. Fhe underlying assiinipdon in this regard is thai dtiring the evolution ofC'FCM,, which begins as an inllaniniatory reactive (i.e. polyclonal) process, a stibj)opiilalion ol 1' cells is sclectivc^ly stimulated to prolileiate (i.e. clonal expansion) \'ia a transloi lualion excnl mediated b\' an c^xternal agent.
Altcrnalively, these cases may represent random sampling of X'^,, from (he 20 VP families. 'Fhis would explain win olhcr cases are V(,3,,-l-and
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Vp,o-t-. The Gilkes report and the Rallkiaer re])ori, however, have the vast maiorily of i:)atients as Vpwith their res])ective Mo.M) panels (28, 32). I (antigenie stimulation is resjionsible (or the majority of CTCL, it would seem that unique antigens are implicated in most of these eases. Ib support the hypothesis ()( chronic antigenic stimulation, all of these cases should have a predominance of some VP gene |)ic)dncts expressed by the malignant F cells. I'hc apparent lack of ])ositi\e Vp staining in these cases may be simply explained by incompleteness of the screening panel of Vp gene family MoAbs. It is also quite possible that at least some of these 'F cell lymi^homas have lost FCIR expression similar to other antigenic loss characteristic of C'FCT, (40) (41) (42) .
An eqnally valid interpretation of these various studies is that Vp gene restriction is not i)reseiit in MF/CTC'L. 'Fhis conclusion is stipporied by DNA studies that have inconsistently shown FCR gene rearrangements in lesional CTCL (12, 20, 21) . If all cases of CTCL represent a clonal expansion of a unique, transformed T eell, then a rearranged TCR gene representing a single VP gene product should be recognized by Southern analysis, as well as tissue staining of frozen sections. The lower limit of sensitivity for Southern analysis is that the rearranged DNA must account (or l-5"/() of the total cellular DNA of the sample (12) . 'Fhus, some false negatives arc^ expected. The lower limit of sensitivity with immunoperoxidase staining should also be 5%. as up to 5% of normal lymphoc-ytes can express any given vp gene product (25, 26) , Variabilities of gene expression, antigenic stimnlus, antibody specificities, patient demographics, and laboratory technique are all factors which apl^ear to make thc^ currc^nt use of VP gene products in the diagnosis of Ml'VCVIX'L suspect. 'Fhese factors are also rc^asons to scrutinize what may be a high rate of "false negative" DN.\ Sotithern analyses in these |)atients, \Mien a comprehensi\ e panel rc^c'ognizing all 20 \ p (amilies becomes available, then and only then will Vp MoAbs become^ useful in searching lor clonal populations in cnitaneons infiltrates. Inexpensive, rapid analysis \ia immunoperoxidase or immunolluorescence of tissue sections could then he peiloinied ()y applying a cocktail of 3-4 vp MoAbs to a series of sections (33) . If prominent staining is seen with any one. then lliat would l)e fiirther stained with each Mo.'Vb iudi\ idually. Ihis tecJinique would allow rapid dissection ol Vp gene |)roduct exjiression in tissties and would also minimize^ ihe use o( \alua()le tissue ancl exi)ensi\c reagents. Ol course, certain subsets ol F cell lymphomas (i)artictiiarly large cell types) may not express 'I'CR despite CD3 expression, and thus in these \arieties, this apjjroach would not be helpful (33) .
l''utiiie a|)i)lic ations of VP gene (amily probes for donality in cutaneous T cell-mediated disease include the use of VP (amily specific primers combinc^d with jjolymerase ehain reaetion (I'CR) technology to increase sensitivity and specificity. McCarthy et al rc^cently reported the use of this tc^chnolcjgy on parallin-embedded sjjeeimens from variety ol'F eell neoplasms ancl suggested sensitivity limits of 0.05% (42) . Similar landmark molecular dissection of C'FCJL by Lessin et al was recently reportc^d in which patient s|)eci(ic primc^rs and jMobc^s were prodtHed to enable very sensivitive analysis of c^arly lesions, as well as retios])ective c^valuatioii ol nonchagnostie specimens (43).
For the moment, the light microsc:opic lecognilion of early Cri'CL remains the "gold standiird", btit it is anticipated that, as molecular biological and inmitinologic:al based probes are developed (| 5C)-tentially c;ombined with PCR), the "midas touch" may be passed on from the anatomic pathologist to the molecular biologist and back to the immunodermatopathcjlogist. Carefully controlled, large series of both benign, reactive, as well as malignant cutaneous lymphoproliferative lesions need to be evaluated before we can seriously consider abandoning our traditional hematoxylin-eosin stained slides.
